Literature DB >> 7931074

Comparison of cell lines deficient in antigen presentation reveals a functional role for TAP-1 alone in antigen processing.

R Gabathuler1, G Reid, G Kolaitis, J Driscoll, W A Jefferies.   

Abstract

Cytotoxic T lymphocytes (CTL) recognize antigenic peptides bound to major histocompatibility complex class I antigens on the cell surface of virus-infected cells. It is believed that the majority of peptides originate from cytoplasmic degradation of proteins assumed to be mediated by the "20S" proteasome. Cytosolic peptides are then translocated, presumably by transporters associated with antigen processing (TAP-1 and -2), into the lumen of the endoplasmic reticulum (ER) where binding and formation of the ternary complex between heavy chain, beta2-microglobulin (beta 2m) and peptide occurs. In this study, we have analyzed and compared the phenotype of two mutant cell lines, the thymoma cell line RMA-S and a small lung carcinoma cell line CMT.64, in order to address the mechanism that underlies the antigen processing deficiency of CMT.64 cells. Unlike RMA-S cells, vesicular stomatitis virus (VSV)-infected CMT.64 cells are not recognized by specific CTL. Interferon gamma (IFN-gamma) treatment of CMT.64 cells restores the ability of these cells to process and present VSV in the context of Kb. We show that although CMT.64 cells express a low level of beta 2m, the recognition of VSV-specific CTL is not restored by increasing the amount of beta 2m synthesized in CMT.64 cells. In addition, we find that CMT.64 cells express moderate levels of Kb heavy chain molecules, but most of it is unstable and rapidly degraded in the absence of IFN-gamma treatment. We infer that the antigen processing deficiency does not lie at the level of beta 2m or Kb production. We find also that the mRNAs for both TAP-1 and -2 are present in RMA and RMA-S cells but are absent in uninduced CMT.64 cells. Upon IFN-gamma induction, both mRNAs are highly expressed in CMT-64 cells. In addition, we find that the low molecular mass polypeptides 2 and 7, and additional components of the proteasome are induced by IFN-gamma in CMT-64 cells. Finally, introduction of the rat TAP-1 gene in CMT.64 cells restores CTL recognition of VSV-infected cells. These results indicate that a TAP-1 homodimer may translocate peptides in the ER and explain partially the CMT.64 defect and the RMA-S phenotype. These findings link a dysfunction in the transport and/or generation of antigenic peptides to the capacity of tumor cells to evade immunosurveillance and provide a unique model system to dissect this phenomenon.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7931074      PMCID: PMC2191686          DOI: 10.1084/jem.180.4.1415

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  51 in total

1.  Major histocompatibility complex (MHC)-encoded HAM2 is necessary for antigenic peptide loading onto class I MHC molecules.

Authors:  Y Yang; K Früh; J Chambers; J B Waters; L Wu; T Spies; P A Peterson
Journal:  J Biol Chem       Date:  1992-06-15       Impact factor: 5.157

2.  Expression of intra-MHC transporter (Ham) genes and class I antigens in diabetes-susceptible NOD mice.

Authors:  H R Gaskins; J J Monaco; E H Leiter
Journal:  Science       Date:  1992-06-26       Impact factor: 47.728

Review 3.  Proteolysis, proteasomes and antigen presentation.

Authors:  A L Goldberg; K L Rock
Journal:  Nature       Date:  1992-06-04       Impact factor: 49.962

4.  Presentation of viral antigen by MHC class I molecules is dependent on a putative peptide transporter heterodimer.

Authors:  T Spies; V Cerundolo; M Colonna; P Cresswell; A Townsend; R DeMars
Journal:  Nature       Date:  1992-02-13       Impact factor: 49.962

5.  Ham-2 corrects the class I antigen-processing defect in RMA-S cells.

Authors:  M Attaya; S Jameson; C K Martinez; E Hermel; C Aldrich; J Forman; K F Lindahl; M J Bevan; J J Monaco
Journal:  Nature       Date:  1992-02-13       Impact factor: 49.962

6.  Proteasomes are regulated by interferon gamma: implications for antigen processing.

Authors:  Y Yang; J B Waters; K Früh; P A Peterson
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

7.  Polymorphism in a second ABC transporter gene located within the class II region of the human major histocompatibility complex.

Authors:  S H Powis; I Mockridge; A Kelly; L A Kerr; R Glynne; U Gileadi; S Beck; J Trowsdale
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-15       Impact factor: 11.205

8.  Allelic variants of the human putative peptide transporter involved in antigen processing.

Authors:  M Colonna; M Bresnahan; S Bahram; J L Strominger; T Spies
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

9.  IFN-gamma-induced recognition of the antigen-processing variant CMT.64 by cytolytic T cells can be replaced by sequential addition of beta 2 microglobulin and antigenic peptides.

Authors:  W A Jefferies; G Kolaitis; R Gabathuler
Journal:  J Immunol       Date:  1993-09-15       Impact factor: 5.422

10.  Assembly and function of the two ABC transporter proteins encoded in the human major histocompatibility complex.

Authors:  A Kelly; S H Powis; L A Kerr; I Mockridge; T Elliott; J Bastin; B Uchanska-Ziegler; A Ziegler; J Trowsdale; A Townsend
Journal:  Nature       Date:  1992-02-13       Impact factor: 49.962

View more
  28 in total

1.  Modulation of transporter associated with antigen processing (TAP)-mediated peptide import into the endoplasmic reticulum by flavivirus infection.

Authors:  F Momburg; A Müllbacher; M Lobigs
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

2.  Tumor signaling to the bone marrow changes the phenotype of monocytes and pulmonary macrophages during urethane-induced primary lung tumorigenesis in A/J mice.

Authors:  Elizabeth F Redente; David J Orlicky; Ronald J Bouchard; Alvin M Malkinson
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

3.  The same major histocompatibility complex polymorphism involved in control of HIV influences peptide binding in the mouse H-2Ld system.

Authors:  Samanthi Narayanan; David M Kranz
Journal:  J Biol Chem       Date:  2013-09-24       Impact factor: 5.157

Review 4.  Molecular mechanisms of class I major histocompatibility complex antigen processing and presentation.

Authors:  Y Yang; P Sempé; P A Peterson
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

Review 5.  Pathways of antigen processing.

Authors:  Janice S Blum; Pamela A Wearsch; Peter Cresswell
Journal:  Annu Rev Immunol       Date:  2013-01-03       Impact factor: 28.527

6.  Epigenetic control of the immune escape mechanisms in malignant carcinomas.

Authors:  A Francesca Setiadi; Muriel D David; Robyn P Seipp; Jennifer A Hartikainen; Rayshad Gopaul; Wilfred A Jefferies
Journal:  Mol Cell Biol       Date:  2007-09-17       Impact factor: 4.272

7.  CD40 induces antigen transporter and immunoproteasome gene expression in carcinomas via the coordinated action of NF-kappaB and of NF-kappaB-mediated de novo synthesis of IRF-1.

Authors:  Aristides Moschonas; Maria Kouraki; Pauline G Knox; Efstathia Thymiakou; Dimitris Kardassis; Aristides G Eliopoulos
Journal:  Mol Cell Biol       Date:  2008-08-11       Impact factor: 4.272

8.  Identification of a TAP-independent, immunoproteasome-dependent CD8+ T-cell epitope in Epstein-Barr virus latent membrane protein 2.

Authors:  Georg Lautscham; Tracey Haigh; Sabine Mayrhofer; Graham Taylor; Debbie Croom-Carter; Alison Leese; Stephan Gadola; Vincenzo Cerundolo; Alan Rickinson; Neil Blake
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

9.  Priming of immune responses against transporter associated with antigen processing (TAP)-deficient tumours: tumour direct priming.

Authors:  Xiao-Lin Li; Dongqing Zhang; David Knight; Yoshinobu Odaka; Jonathan Glass; J Michael Mathis; Qian-Jin Zhang
Journal:  Immunology       Date:  2009-11       Impact factor: 7.397

10.  Effect of B7.1 costimulation on T-cell based immunity against TAP-negative cancer can be facilitated by TAP1 expression.

Authors:  Xiao-Lin Li; Yong-Yu Liu; David Knight; Yoshinobu Odaka; J Michael Mathis; Runhua Shi; Jonathan Glass; Qian-Jin Zhang
Journal:  PLoS One       Date:  2009-07-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.